论文部分内容阅读
硝普钠作为扩血管药物近几年来逐渐广泛地应用于心功能不全的治疗,尤其是重症患者,临床应用后取得了很好的疗效,我们将其与酚妥拉明进行了对比观察,现报告如下。1临床资料1.1病例选择本文所选病例均为我院2000年4月～2003年6月住院的心功能2-4级(NYHA分级)患者,共294例。男198例,女96例,年龄35-78岁,平均年龄62.3岁。心功能2级48例,3级154例,4级92例,其中高血压性心脏病143例,冠心病96例,肺心病34例,扩张性心肌病17例,风湿性心脏病4例。血压90～220/60-115mmHg(1mmHg=
Sodium nitroprusside as vasodilator drugs in recent years, gradually widely used in the treatment of cardiac insufficiency, especially in critically ill patients, after clinical application has achieved good effect, we compared it with phentolamine, now The report is as follows. 1 Clinical data 1.1 Case Selection The selected cases were hospitalized in our hospital from April 2000 to June 2003 cardiac function grade 2-4 (NYHA classification) patients, a total of 294 cases. 198 males and 96 females, aged 35-78 years old, with an average age of 62.3 years. There were 48 cases of grade 2, 154 cases of grade 3 and 92 cases of grade 4, including 143 cases of hypertensive heart disease, 96 cases of coronary heart disease, 34 cases of pulmonary heart disease, 17 cases of dilated cardiomyopathy and 4 cases of rheumatic heart disease. Blood pressure 90 ~ 220 / 60-115mmHg (1mmHg =